HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Examining the factor structure of the Clinical Opiate Withdrawal Scale: A secondary data analysis from the National Drug Abuse Treatment Clinical Trials Network (CTN) 0003.

AbstractBACKGROUND:
The Clinical Opiate Withdrawal Scale (COWS) is used to assess withdrawal in clinical trials and practice. The aims of this study were to examine the inter-item correlations and factor structure of the COWS in opioid-dependent men and women.
METHODS:
This is a secondary data analysis of the National Drug Abuse Treatment Clinical Trials Network 0003, a randomized clinical trial that compared buprenorphine/naloxone tapering strategies. The trial included 11 sites in 10 US cities. Participants were opioid-dependent individuals (n=516) that had data on the COWS. The COWS at study baseline was analyzed in this study.
RESULTS:
Inter-item correlations showed weak to moderate relationships among the items. A 1-factor model did not fit the data for men (comparative fit index (CFI)=.801, root mean square error of approximation (RMSEA)=.073, weighted root mean square residual (WRMR)=1.132) or women (CFI=.694, RMSEA=.071, WRMR=.933), where resting pulse rate was not related to withdrawal for men, and yawning and gooseflesh skin was not related to withdrawal for women. A reduced model comprised of only the 8 items that were significantly related to the construct of withdrawal in both men and women, and an exploratory 2-factor model, were also assessed but not retained due to inconsistencies across gender.
CONCLUSIONS:
When traditional psychometric models are applied to the COWS, it appears that the scale may not relate to a single underlying construct of withdrawal. Further research testing the hypothesized factor structure in other opioid-dependent samples is needed.
AuthorsCelestina Barbosa-Leiker, Sterling McPherson, Mary Rose Mamey, G Leonard Burns, Matthew E Layton, John Roll, Walter Ling
JournalDrug and alcohol dependence (Drug Alcohol Depend) Vol. 152 Pg. 218-23 (Jul 01 2015) ISSN: 1879-0046 [Electronic] Ireland
PMID25908321 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
CopyrightCopyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Analgesics, Opioid
  • Buprenorphine, Naloxone Drug Combination
Topics
  • Analgesics, Opioid (therapeutic use)
  • Buprenorphine, Naloxone Drug Combination (therapeutic use)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Opioid-Related Disorders (diagnosis, drug therapy)
  • Psychometrics
  • Randomized Controlled Trials as Topic
  • Substance Withdrawal Syndrome (diagnosis, drug therapy)
  • United States

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: